Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 4
2021 4
2022 1
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Prolactin and oxytocin: potential targets for migraine treatment.
Szewczyk AK, Ulutas S, Aktürk T, Al-Hassany L, Börner C, Cernigliaro F, Kodounis M, Lo Cascio S, Mikolajek D, Onan D, Ragaglini C, Ratti S, Rivera-Mancilla E, Tsanoula S, Villino R, Messlinger K, Maassen Van Den Brink A, de Vries T; European Headache Federation School of Advanced Studies (EHF-SAS). Szewczyk AK, et al. Among authors: de vries t. J Headache Pain. 2023 Mar 27;24(1):31. doi: 10.1186/s10194-023-01557-6. J Headache Pain. 2023. PMID: 36967387 Free PMC article. Review.
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine.
Deligianni CI, Sacco S, Ekizoglu E, Uluduz D, Gil-Gouveia R, MaassenVanDenBrink A, Ornello R, Sanchez-Del-Rio M, Reuter U, Versijpt J, de Vries T, Hussain M, Zeraatkar D, Lampl C. Deligianni CI, et al. Among authors: de vries t. J Headache Pain. 2023 Sep 19;24(1):128. doi: 10.1186/s10194-023-01657-3. J Headache Pain. 2023. PMID: 37723437 Free PMC article. Review.
Headache medication and the COVID-19 pandemic.
MaassenVanDenBrink A, de Vries T, Danser AHJ. MaassenVanDenBrink A, et al. Among authors: de vries t. J Headache Pain. 2020 Apr 25;21(1):38. doi: 10.1186/s10194-020-01106-5. J Headache Pain. 2020. PMID: 32334535 Free PMC article.
Evaluating rimegepant for the treatment of migraine.
de Vries T, Al-Hassany L, MaassenVanDenBrink A. de Vries T, et al. Expert Opin Pharmacother. 2021 Jun;22(8):973-979. doi: 10.1080/14656566.2021.1895749. Epub 2021 Mar 10. Expert Opin Pharmacother. 2021. PMID: 33648385
Blocking the CGRP Receptor: Differences across Human Vascular Beds.
de Vries T, Boucherie DM, van den Bogaerdt A, Danser AHJ, MaassenVanDenBrink A. de Vries T, et al. Pharmaceuticals (Basel). 2023 Jul 28;16(8):1075. doi: 10.3390/ph16081075. Pharmaceuticals (Basel). 2023. PMID: 37630989 Free PMC article.
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline.
Lampl C, Versijpt J, Amin FM, Deligianni CI, Gil-Gouveia R, Jassal T, MaassenVanDenBrink A, Ornello R, Paungarttner J, Sanchez-Del-Rio M, Reuter U, Uluduz D, de Vries T, Zeraatkar D, Sacco S. Lampl C, et al. Among authors: de vries t. J Headache Pain. 2023 Apr 11;24(1):39. doi: 10.1186/s10194-023-01573-6. J Headache Pain. 2023. PMID: 37038134 Free PMC article.
18 results